Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each;Papaverine, solution for injection, 20 mg/ml, 2 ml each;Sodium chloride, solution for injection, 9 mg/ml, 5 ml each;Furosemide, solution for injection, 10 mg/ml, 2 ml each;Chloropyramine, solution for injection, 20 mg/ml, 1 ml each;Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each;Metamizole sodium, solution for injection, 500 mg/ml, 2 ml;Prednisone, solution for injection, 30 mg/ml, 1 ml each;Theophylline solution for in
By: Nina Malyukina๐ UkraineClosed
Key Information
| Reference | GB-UA-2026-11-04-015895-a |
|---|
| Deadline | Nov 9, 2026 12:00 AM |
|---|
| Estimated Value | UAH 1,400,000.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 67700, Ukraine, Odesa region, city of Bilhorod-Dnistrovskyi, PYROHOVA STREET, building 4 |
|---|
| Published | Nov 5, 2026 |
|---|
Description
Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each;Papaverine, solution for injection, 20 mg/ml, 2 ml each;Sodium chloride, solution for injection, 9 mg/ml, 5 ml each;Furosemide, solution...
Full details are available after unlocking this tender.